Literature DB >> 11904652

Evidence-based medicine in the therapy of the acute respiratory distress syndrome.

Rüdger Kopp1, Ralf Kuhlen, Martin Max, Rolf Rossaint.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904652     DOI: 10.1007/s00134-002-1232-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  Hidden evidence to the West: multicentre, randomised, controlled trials in sepsis and systemic inflammatory response syndrome in Japanese journals.

Authors:  Rinaldo Bellomo; Shigehiko Uchino; Toshio Naka; Li Wan
Journal:  Intensive Care Med       Date:  2004-03-30       Impact factor: 17.440

Review 2.  Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.

Authors:  Magda Cepkova; Michael A Matthay
Journal:  J Intensive Care Med       Date:  2006 May-Jun       Impact factor: 3.510

3.  Multislice spiral computed tomography to determine the effects of a recruitment maneuver in experimental lung injury.

Authors:  Dietrich Henzler; Andreas H Mahnken; Joachim E Wildberger; Rolf Rossaint; Rolf W Günther; Ralf Kuhlen
Journal:  Eur Radiol       Date:  2005-10-12       Impact factor: 5.315

4.  [Treatment of acute respiratory distress syndrome in a treatment center. Success is dependent on risk factors].

Authors:  D Henzler; R Dembinski; R Kopp; R Hawickhorst; R Rossaint; R Kuhlen
Journal:  Anaesthesist       Date:  2004-03       Impact factor: 1.041

Review 5.  [Extracorporeal membrane oxygenation by acute respiratory distress syndrome].

Authors:  R Kopp; D Henzler; R Dembinski; R Kuhlen
Journal:  Anaesthesist       Date:  2004-02       Impact factor: 1.041

6.  Validation of RESP and PRESERVE score for ARDS patients with pumpless extracorporeal lung assist (pECLA).

Authors:  Jan Petran; Thorsten Muelly; Rolf Dembinski; Niklas Steuer; Jutta Arens; Gernot Marx; Ruedger Kopp
Journal:  BMC Anesthesiol       Date:  2020-05-02       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.